Varro A, Nakaya Y, Elharrar V, Surawicz B
J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):178-85. doi: 10.1097/00005344-198601000-00026.
We examined the steady-state action potential duration (APD) within a wide range of cycle lengths (CL) in cardiac dog Purkinje (P) and ventricular (V) muscle fibers in the presence of: lidocaine (L) 4 and 8 micrograms/ml, mexiletine (M) 4 and 8 micrograms/ml, flecainide (F) 1 and 4 micrograms/ml, disopyramide (D) 3.1 and 10 micrograms/ml, quinidine (Q) 2.5, 5, and 10 micrograms/ml, bretylium tosylate (B) 5 and 10 micrograms/ml, and sotalol (S) 5 micrograms/ml. In the P fibers, all drugs except for B and S shortened plateau duration, increased slope of phase 2 and decreased slope of phase 3 repolarization, and either shortened (L, M, Q, F) or prolonged (D) APD. B and S lengthened APD and did not change significantly the slopes of phase 2 and 3 of repolarization. Each drug altered the relation between APD and Cl according to one of the following three patterns: (a) L, M, Q, and F shortened APD more at long than at short CL; (b) D lengthened APD more at short than at long CL; (c) B and S lengthened APD more at long that at short CL. In the V fibers, APD was lengthened by F, Q, and B, and shortened by L and M. The drug-induced changes in the relation between APD and CL were as in the P fibers. The results suggest that the drug-induced changes in the relation between APD and CL can be predicted from the drug effects on the course of repolarization.
我们在犬心脏浦肯野(P)纤维和心室(V)肌纤维中,于多种心动周期长度(CL)范围内,检测了稳态动作电位时程(APD),所用药物包括:4微克/毫升和8微克/毫升的利多卡因(L)、4微克/毫升和8微克/毫升的美西律(M)、1微克/毫升和4微克/毫升的氟卡尼(F)、3.1微克/毫升和10微克/毫升的丙吡胺(D)、2.5微克/毫升、5微克/毫升和10微克/毫升的奎尼丁(Q)、5微克/毫升和10微克/毫升的溴苄铵(B)以及5微克/毫升的索他洛尔(S)。在P纤维中,除B和S外,所有药物均缩短了平台期时程,增加了2期斜率并降低了3期复极化斜率,且要么缩短了(L、M、Q、F)要么延长了(D)APD。B和S延长了APD,且未显著改变复极化2期和3期的斜率。每种药物根据以下三种模式之一改变了APD与CL之间的关系:(a)L、M、Q和F在长CL时比在短CL时更显著地缩短APD;(b)D在短CL时比在长CL时更显著地延长APD;(c)B和S在长CL时比在短CL时更显著地延长APD。在V纤维中,F、Q和B延长了APD,而L和M缩短了APD。药物诱导的APD与CL关系的变化与P纤维中的情况相同。结果表明,药物诱导的APD与CL关系的变化可根据药物对复极化过程的影响来预测。